GRAIL, LLC (GRAL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, GRAIL, LLC (GRAL) has a cash flow conversion efficiency ratio of -0.032x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-80.73 Million) by net assets ($2.54 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of GRAIL, LLC for the company's overall valuation and market capitalisation.
GRAIL, LLC - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how GRAIL, LLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.
GRAIL, LLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of GRAIL, LLC ranked by their cash flow conversion efficiency. See GRAIL, LLC (GRAL) debt coverage ratio to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Grupa KĘTY SA
WAR:KTY
|
0.077x |
|
Addsino Co Ltd
SHE:000547
|
0.049x |
|
HNI Corp
NYSE:HNI
|
-0.018x |
|
New Hope Corporation Ltd
AU:NHC
|
0.071x |
|
Sinotruk Jinan Truck Co Ltd
SHE:000951
|
0.125x |
|
SunocoCorp LLC
NYSE:SUNC
|
0.003x |
|
PennyMac Finl Svcs Inc
NYSE:PFSI
|
0.472x |
|
Adtalem Global Education Inc
NYSE:ATGE
|
0.022x |
Annual Cash Flow Conversion Efficiency for GRAIL, LLC (2018–2025)
The table below shows the annual cash flow conversion efficiency of GRAIL, LLC from 2018 to 2025. View GRAL share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $2.58 Billion | $-299.01 Million | -0.116x | +49.69% |
| 2024-12-31 | $2.50 Billion | $-577.16 Million | -0.231x | -41.09% |
| 2023-12-31 | $3.65 Billion | $-595.80 Million | -0.163x | -35.25% |
| 2022-12-31 | $4.65 Billion | $-561.31 Million | -0.121x | -65.57% |
| 2021-12-31 | $9.43 Billion | $-688.13 Million | -0.073x | +82.33% |
| 2020-12-31 | $561.84 Million | $-232.00 Million | -0.413x | +7.51% |
| 2019-12-31 | $550.53 Million | $-245.79 Million | -0.446x | -28.09% |
| 2018-12-31 | $600.37 Million | $-209.26 Million | -0.349x | -- |
About GRAIL, LLC
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides deve… Read more